Bach is a passionate advocate for patients and often eloquently expresses concerns on the high prices of drugs, particularly new cancer therapies. When he speaks, many people pay close attention. However, his guest post on Forbes.com entitled "Could High Drug Prices Be Bad For Innovation" unfortunately is off-base.